RASHMI KRISHNA MURTHY to Chemotherapy, Adjuvant
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Chemotherapy, Adjuvant.
Connection Strength
0.089
-
Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer. Cancer. 2014 Jul 01; 120(13):1932-8.
Score: 0.065
-
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
Score: 0.024